Almost no other sectors are so much characterized by research and development as medicine and health, pharmaceuticals, and biotechnology.
These are the areas where new ground is broken and complex legal issues frequently arise. The best example is the COVID-19 pandemic that calls for swift resolution of legal issues relating to data collection and digitalization so that innovations can benefit society. New technical possibilities in the healthcare sector are also leading to new business models and sources of revenue for data-processing companies – if the legal basis is right. Our experts accompany renowned research institutions and biotech start-ups as well as international pharmaceutical companies.